ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis

Nephrology Dialysis Transplantation

Volumn 29, Issue 9, 2014, Pages 1764-1769

  Quintana, Luis F ^a,b   Peréz, Nuria S ^b   De Sousa, Erika ^a   Rodas, Lida M ^b   Griffiths, Meryl H ^c   Solé, Manel ^d   Jayne, David ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

ANCA; Glomerulonephritis; Histopathology; Outcome; Vasculitis

Indexed keywords

MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PEROXIDASE;

ADULT; ANCA ASSOCIATED GLOMERULONEPHRITIS; ANCA ASSOCIATED VASCULITIS; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SEROTYPE; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; CHRONIC KIDNEY FAILURE; COMPLICATION; GLOMERULUS; IMMUNOLOGY; PATHOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; PEROXIDASE; RETROSPECTIVE STUDIES; SEROGROUP; SEVERITY OF ILLNESS INDEX;

EID: 84907386206     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu084     Document Type: Article

References (26)

1. Franssen CF, Stegeman CA, Kallenberg CG et al. Antiproteinase 3- and antimyeloperoxidase associated vasculitis. Kidney Int 2000; 57: 2195-2206
2. Lionaki S, Blyth ER, Hogan SL et al. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 2012; 64: 3452-3462
3. Jennette JC, Falk RJ, Bacon PA et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65: 1-11
4. Lyons PA, Rayner TF, Trivedi S et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012; 367: 214-223
5. Little MA, Al-Ani B, Ren S et al. Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system. PLoS ONE 2012; 7: e28626
6. Fujimoto S, Watts RA, Kobayashi S et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK. Rheumatology 2011; 50: 1916-1920
7. Chen M, Cui Z, Zhao MH. ANCA-associated vasculitis and anti-GBM disease: the experience in China. Nephrol Dial Transplant 2010; 25: 2062-2065
8. Hogan SL, Cooper GS, Savitz DA et al. Association of silica exposure with antineutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study. Clin J Am Soc Nephrol 2007; 2: 290-299
9. Ten Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother 2002; 36: 130-147
10. Hauer HA, Bajema IM, van Houwelingen HC et al. European Vasculitis Study Group (EUVAS).Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 2002; 61: 80-89
11. Jayne DR, Gaskin G, Rasmussen N et al. European Vasculitis Study Group. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007; 18: 2180-2188
12. Berden AE, Ferrario F, Hagen EC et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 2010; 21: 1628-1636
13. Hilhorst M, Wilde B, van Breda Vriesman P et al. Limburg Renal Registry. Estimating renal survival using the ANCA-associated GN classification. J Am Soc Nephrol 2013; 24: 1371-1375
14. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
15. Senn S, Stevens L, Chaturvedi N. Repeated measures in clinical trials: simple strategies for analysis using summary measures. Stat Med 2000; 19: 861-877
16. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266
17. Bajema IM, Hagen EC, Hansen BE et al. The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreement. Nephrol Dial Transplant 1996; 11: 1989-1995
18. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification for renal allograft pathology. Kidney Int 1999; 55: 713-723
19. Chang DY, Wu LH, Liu G et al. Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant 2012; 27: 2343-2349
20. Ellis CL, Manno RL, Havill JP et al. Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcome. BMC Nephrol 2013; 14: 210. doi:10.1186/1471- 2369-14-210
21. Vergunst CE, van Gurp E, Hagen EC et al. EC/BCR Project for ANCA-Assay Standardisation l. An index for renal outcome in ANCA-associated glomerulonephritis. Am J Kidney Dis 2003; 41: 532-538
22. Hauer HA, Bajema IM, Van Houwelingen HC et al. European Vasculitis Study Group (EUVAS). Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 2002; 62: 1732-1742
23. Berden AE, Jones RB, Erasmus DD et al. European Vasculitis Society. Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy. J Am Soc Nephrol 2012; 23: 313-321
24. Hauer HA, Bajema IM, Hagen EC et al. Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies. Nephrol Dial Transplant 2002; 17: 587-596
25. Neumann I, Kain R, Regele H et al. Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant 2005; 20: 96-104
26. Tam FW, Sanders JS, George A et al. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol Dial Transplant 2004; 19: 2761-2768